A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Citadel Advisors LLC holds 62,300 shares of PROK stock, worth $105,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,300
Previous 76,600 18.67%
Holding current value
$105,287
Previous $188,000 36.7%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.2 - $1.76 $10,224 - $14,995
-8,520 Reduced 58.29%
6,096 $9,000
Q4 2023

Feb 14, 2024

BUY
$1.21 - $4.76 $17,685 - $69,572
14,616 New
14,616 $26,000
Q2 2023

Aug 14, 2023

BUY
$9.0 - $13.0 $8,100 - $11,700
900 New
900 $10,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $104M
More about PROK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.